AstraZeneca COVID-19 vaccine trial on hold

Late-stage studies of AstraZeneca's COVID-19 vaccine candidate, being developed by Oxford University, are on temporary hold while the firm investigates whether a recipient's "potentially unexplained" illness is a side effect of the shot. In a statement on Tuesday evening, the company said its "standard review process triggered a...